ALHC - Alignment Healthcare, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$24.83
DETAILS
HIGH:
$30.00
LOW:
$19.00
MEDIAN:
$25.00
CONSENSUS:
$24.83
UPSIDE:
51.87%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 3,948.7 | 2,703.6 | 1,823.6 | 1,434.2 | 1,167.8 | 959.2 | 757.0 |
| Cost of Revenue | 3,460.2 | 2,406.9 | 1,622.6 | 1,249.9 | 1,039.0 | 793.0 | 661.4 |
| Gross Profit | 488.6 | 296.7 | 201.0 | 184.3 | 128.7 | 166.2 | 95.6 |
| Operating Expenses | |||||||
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A Expenses | 0 | 371.4 | 307.4 | 295.6 | 291.0 | 156.4 | 110.1 |
| Other Expenses | 473.8 | 26.9 | 21.4 | 17.3 | 15.8 | 15.1 | 14.9 |
| Operating Expenses | 473.8 | 398.2 | 328.8 | 312.9 | 306.8 | 171.5 | 125.1 |
| Operating Income | |||||||
| Operating Income | 14.8 | (101.6) | (127.8) | (128.6) | (178.1) | (5.3) | (29.5) |
| Interest Expense | 15.8 | 23.5 | 21.2 | 18.3 | 17.4 | 16.9 | 14.9 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||
| EBITDA | 45.3 | (77.4) | (105.3) | (113.5) | (161.8) | 9.5 | (13.3) |
| EBIT | 14.8 | (104.5) | (127.0) | (131.0) | (177.8) | (6.0) | (29.8) |
| Income Before Tax | (1.0) | (128.1) | (148.2) | (149.3) | (195.3) | (22.9) | (44.7) |
| Income Tax Expense | 0.0 | 0.0 | (0.0) | 0.3 | 0 | 0 | 0 |
| Net Income | (0.7) | (128.0) | (148.0) | (149.5) | (195.3) | (22.9) | (44.7) |
| Per Share Data | |||||||
| EPS (Basic) | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 | -0.12 | -0.29 |
| EPS (Diluted) | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 | -0.12 | -0.29 |
| Shares Outstanding | 198.0 | 190.8 | 186.2 | 181.2 | 172.0 | 187.3 | 152.1 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 577.9 | 432.9 | 202.9 | 409.5 | 466.6 | 207.3 | 86.5 |
| Short-Term Investments | 0 | 37.8 | 115.9 | 0 | 0 | 0 | 0 |
| Net Receivables | 253.2 | 153.9 | 119.7 | 92.9 | 58.5 | 40.1 | 35.6 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 37.1 | 45.0 | 42.1 | 0 | 0 | 0 |
| Total Current Assets | 831.1 | 661.6 | 483.5 | 544.5 | 552.9 | 264.7 | 127.4 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 71.3 | 75.0 | 61.9 | 43.0 | 38.2 | 37.0 | 27.4 |
| Goodwill | 32.1 | 34.8 | 34.8 | 34.8 | 29.3 | 29.3 | 29.3 |
| Intangible Assets | 4.5 | 4.5 | 5.3 | 5.5 | 5.8 | 5.3 | 5.7 |
| Long-Term Investments | 28.4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 98.3 | 6.1 | 6.4 | 6.0 | 4.7 | 2.1 | 3.7 |
| Total Non-Current Assets | 234.6 | 120.4 | 108.3 | 89.3 | 78.0 | 73.8 | 66.1 |
| Total Assets | 1,065.8 | 782.1 | 591.9 | 633.9 | 630.9 | 338.5 | 193.4 |
| Current Liabilities | |||||||
| Account Payables | 474.6 | 242.5 | 170.1 | 171.9 | 17.4 | 128.3 | 117.7 |
| Short-Term Debt | 2.0 | 1.2 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 38.7 | 34.1 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 476.5 | 351.8 | 263.0 | 230.0 | 167.2 | 153.5 | 130.3 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 323.2 | 321.4 | 161.8 | 160.9 | 150.6 | 144.2 | 138.0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 73.9 | 0 | 0 | 0 | 0 | 0 | 3.9 |
| Total Non-Current Liabilities | 410.0 | 329.3 | 170.8 | 164.6 | 157.6 | 154.4 | 141.9 |
| Total Liabilities | 886.5 | 681.1 | 433.8 | 394.6 | 324.8 | 307.9 | 272.2 |
| Stockholders' Equity | |||||||
| Common Stock | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0 |
| Retained Earnings | (1,009.0) | (1,008.3) | (880.3) | (732.2) | (582.7) | (379.6) | (78.7) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 179.3 | 99.9 | 156.9 | 238.1 | 306.0 | 30.6 | (78.7) |
| Total Liabilities & Equity | 1,065.8 | 782.1 | 591.9 | 633.9 | 630.9 | 338.5 | 193.4 |
| Debt Metrics | |||||||
| Total Debt | 338.1 | 329.3 | 170.8 | 164.6 | 157.6 | 154.4 | 138.0 |
| Net Debt | (239.9) | (103.6) | (32.1) | (244.9) | (309.0) | (52.9) | 51.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (0.7) | (128.1) | (148.2) | (149.6) | (195.3) | (22.9) | (44.7) |
| Depreciation & Amortization | 30.5 | 27.1 | 21.7 | 17.5 | 16.0 | 15.5 | 16.6 |
| Stock-Based Compensation | 62.1 | 71.1 | 66.8 | 81.7 | 110.6 | 2.1 | 1.2 |
| Change in Working Capital | 45.5 | 60.9 | 2.0 | (5.6) | (19.4) | 3.3 | 29.0 |
| Other Non-Cash Items | 2.6 | 3.8 | (1.5) | 10.6 | 9.3 | 9.6 | 7.2 |
| Operating Cash Flow | 139.9 | 34.8 | (59.2) | (45.4) | (78.8) | 7.6 | 9.2 |
| Investing Activities | |||||||
| Capital Expenditure | (26.8) | (41.4) | (36.0) | (23.8) | (18.4) | (15.7) | (10.2) |
| Acquisitions | 1.1 | 0 | 0 | (4.0) | 0 | 0 | 0 |
| Purchases of Investments | (65.6) | (82.2) | (379.1) | (2.8) | (2.5) | (1.6) | (0.3) |
| Sales/Maturities of Investments | 76.3 | 162.8 | 267.8 | 2.4 | 1.4 | 0.8 | 0.3 |
| Other Investing Activities | 0 | 0.0 | 0 | 0 | (1.4) | 0.1 | 0 |
| Investing Cash Flow | (15.0) | 39.2 | (147.3) | (28.2) | (20.8) | (16.4) | (10.2) |
| Financing Activities | |||||||
| Net Debt Issuance | 0 | 165 | 0 | 21.8 | 0 | 0 | 55 |
| Stock Repurchased | 0 | (0.3) | 0 | 0 | (1.5) | (1.5) | (2.0) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.0) | (8.6) | 0.1 | (5.2) | (29.0) | (3.4) | (0.9) |
| Financing Cash Flow | 18.0 | 156.0 | 0.1 | 16.6 | 360.1 | 130.1 | 52.7 |
| Cash Position | |||||||
| Net Change in Cash | 143.0 | 230.0 | (206.3) | (57.1) | 260.5 | 121.3 | 51.6 |
| Cash at Beginning | 434.9 | 205.0 | 411.3 | 468.4 | 207.8 | 86.5 | 34.9 |
| Cash at End | 577.9 | 434.9 | 205.0 | 411.3 | 468.4 | 207.8 | 86.5 |
| Free Cash Flow | 113.1 | (6.6) | (95.2) | (69.2) | (97.1) | (8.1) | (1.0) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 3,948.7 | 2,703.6 | 1,823.6 | 1,434.2 | 1,167.8 | 959.2 | 757.0 |
| Gross Profit | 488.6 | 296.7 | 201.0 | 184.3 | 128.7 | 166.2 | 95.6 |
| Operating Income | 14.8 | (101.6) | (127.8) | (128.6) | (178.1) | (5.3) | (29.5) |
| Net Income | (0.7) | (128.0) | (148.0) | (149.5) | (195.3) | (22.9) | (44.7) |
| EPS (Diluted) | -0.00 | -0.67 | -0.79 | -0.83 | -1.14 | -0.12 | -0.29 |
| Balance Sheet | |||||||
| Cash & Equivalents | 577.9 | 432.9 | 202.9 | 409.5 | 466.6 | 207.3 | 86.5 |
| Total Assets | 1,065.8 | 782.1 | 591.9 | 633.9 | 630.9 | 338.5 | 193.4 |
| Total Debt | 338.1 | 329.3 | 170.8 | 164.6 | 157.6 | 154.4 | 138.0 |
| Stockholders' Equity | 179.3 | 99.9 | 156.9 | 238.1 | 306.0 | 30.6 | (78.7) |
| Cash Flow | |||||||
| Operating Cash Flow | 139.9 | 34.8 | (59.2) | (45.4) | (78.8) | 7.6 | 9.2 |
| Capital Expenditure | (26.8) | (41.4) | (36.0) | (23.8) | (18.4) | (15.7) | (10.2) |
| Free Cash Flow | 113.1 | (6.6) | (95.2) | (69.2) | (97.1) | (8.1) | (1.0) |